Clinical Trials
5 trialsNCT05218226 2025-02-24
Avatrombopag for Chemotherapy-induced Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China
Phase 2 Unknown
NCT06001567 2023-09-14
Avatrombopag for HCC Patients With Thrombocytopenia Who Intend to Undergo TACE and/or HAIC
Second Affiliated Hospital of Guangzhou Medical University
Phase 2 Unknown
NCT05087459 2021-10-21
Treatment of Avatrombopag for Thrombocytopenia in Patients Undergoing Selective Resection of Hepatocellular Carcinoma
Shanghai Zhongshan Hospital
Unknown
NCT04896528 2021-05-21
Efficacy and Safety of Avatrombopag in Cancer Patients With Thrombocytopenia
Peking Union Medical College Hospital
Phase 2 Unknown
NCT04797182 2021-03-15
Avatrombopag for the Primary Prevention of Thrombocytopenia Induced by Cytarabine-based Chemotherapy in Patients With Lymphoma
Sun Yat-sen University
Phase 2 Unknown